BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28228478)

  • 1. An engineered transforming growth factor β (TGF-β) monomer that functions as a dominant negative to block TGF-β signaling.
    Kim SK; Barron L; Hinck CS; Petrunak EM; Cano KE; Thangirala A; Iskra B; Brothers M; Vonberg M; Leal B; Richter B; Kodali R; Taylor AB; Du S; Barnes CO; Sulea T; Calero G; Hart PJ; Hart MJ; Demeler B; Hinck AP
    J Biol Chem; 2017 Apr; 292(17):7173-7188. PubMed ID: 28228478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.
    Radaev S; Zou Z; Huang T; Lafer EM; Hinck AP; Sun PD
    J Biol Chem; 2010 May; 285(19):14806-14. PubMed ID: 20207738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule.
    Qian SW; Burmester JK; Tsang ML; Weatherbee JA; Hinck AP; Ohlsen DJ; Sporn MB; Roberts AB
    J Biol Chem; 1996 Nov; 271(48):30656-62. PubMed ID: 8940041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
    del Re E; Babitt JL; Pirani A; Schneyer AL; Lin HY
    J Biol Chem; 2004 May; 279(21):22765-72. PubMed ID: 14996829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding Properties of the Transforming Growth Factor-β Coreceptor Betaglycan: Proposed Mechanism for Potentiation of Receptor Complex Assembly and Signaling.
    Villarreal MM; Kim SK; Barron L; Kodali R; Baardsnes J; Hinck CS; Krzysiak TC; Henen MA; Pakhomova O; Mendoza V; O'Connor-McCourt MD; Lafer EM; López-Casillas F; Hinck AP
    Biochemistry; 2016 Dec; 55(49):6880-6896. PubMed ID: 27951653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs.
    Huang T; David L; Mendoza V; Yang Y; Villarreal M; De K; Sun L; Fang X; López-Casillas F; Wrana JL; Hinck AP
    EMBO J; 2011 Apr; 30(7):1263-76. PubMed ID: 21423151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to high affinity binding.
    De Crescenzo G; Pham PL; Durocher Y; O'Connor-McCourt MD
    J Mol Biol; 2003 May; 328(5):1173-83. PubMed ID: 12729750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
    Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T
    J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different domains regulate homomeric and heteromeric complex formation among type I and type II transforming growth factor-beta receptors.
    Rechtman MM; Nakaryakov A; Shapira KE; Ehrlich M; Henis YI
    J Biol Chem; 2009 Mar; 284(12):7843-52. PubMed ID: 19147499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational modeling of TGF-β2:TβRI:TβRII receptor complex assembly as mediated by the TGF-β coreceptor betaglycan.
    Madamanchi A; Ingle M; Hinck AP; Umulis DM
    Biophys J; 2023 Apr; 122(7):1342-1354. PubMed ID: 36869592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
    Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
    J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.
    Tazat K; Hector-Greene M; Blobe GC; Henis YI
    Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells.
    Wells RG; Gilboa L; Sun Y; Liu X; Henis YI; Lodish HF
    J Biol Chem; 1999 Feb; 274(9):5716-22. PubMed ID: 10026191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent.
    Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP
    J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta (TGF-beta) type I and type II receptors are both required for TGF-beta-mediated extracellular matrix production in lung fibroblasts.
    Zhao Y
    Mol Cell Endocrinol; 1999 Apr; 150(1-2):91-7. PubMed ID: 10411303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
    Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
    J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs.
    Baardsnes J; Hinck CS; Hinck AP; O'Connor-McCourt MD
    Biochemistry; 2009 Mar; 48(10):2146-55. PubMed ID: 19161338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor.
    Rotzer D; Roth M; Lutz M; Lindemann D; Sebald W; Knaus P
    EMBO J; 2001 Feb; 20(3):480-90. PubMed ID: 11157754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.
    Deng X; Bellis S; Yan Z; Friedman E
    Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
    Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
    Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.